Countermovement Jump Performance and Sprint Speed in Chilean Adolescent Athletes: Does the Association Differ by Sex?
Applied Sciences · 30.10.2026 · 16 (21) · 10773
DOI: 10.3390/app162110773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 30.10.2026. Verfasst von Claudio Hernández-Mosqueira und 10 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study examined the relationship between countermovement jump (CMJ) performance and sprint speed in adolescent athletes, considering anthropometric variables and potential sex differences.
Methods
A descriptive-correlational study was conducted with 140 athletes (43 females and 97 males, aged 14–17 years) from the Promesas Ñuble program in Chile. Body composition, biological maturation, flexibility, vertical jump performance, and 10 and 20 m sprint performance were assessed using standardized protocols.
Results
CMJ performance was strongly and negatively correlated with 20 m sprint time (r ≈ −0.76), indicating that greater jump heights were associated with faster sprint times. In the multiple linear regression analysis, CMJ emerged as the strongest predictor of 20 m sprint time, with the overall model explaining approximately 61% of the variance (R2 = 0.608; adjusted R2 = 0.594). A significant CMJ × sex interaction was observed in the primary analysis (B = −0.0217 s·cm−1, 95% CI [−0.0414, −0.0019], p = 0.032). Sex-stratified analyses showed a negative association between CMJ and sprint time in males (B = −0.0267 s·cm−1, 95% CI [−0.0343, −0.0190], p < 0.001), whereas the female-specific estimate was less precise and its confidence interval included zero (B = −0.0240 s·cm−1, 95% CI [−0.0542, 0.0062], p = 0.116). However, influence diagnostics identified one valid but highly influential observation in the female subgroup (Cook’s D = 1.238). In a sensitivity analysis excluding this observation, the CMJ × sex interaction was attenuated and no longer statistically significant (B = −0.0051 s·cm−1, 95% CI [−0.0226, 0.0125], p = 0.568), indicating that evidence for sex-specific differences was sensitive to this observation.
Conclusions
CMJ performance was strongly associated with 20 m sprint performance in adolescent athletes. Although the primary analysis suggested that this association differed by sex, sensitivity analysis showed that the interaction was substantially influenced by one valid influential observation in the female subgroup. These findings support an association between CMJ and sprint performance but indicate that sex-specific differences require confirmation in larger and more balanced samples.
Zitieren
APA
Hernández-Mosqueira, C., Luna-Villouta, P., Castillo-Quezada, H., Delgado-Floody, P., Pavez-Adasme, G., Peña-Troncoso, S., Hermosilla-Palma, F., Espinoza-Gutiérrez, R., Calleja-Nuñez, J. J., Aburto-Corona, J. A., & Leschot-Gatica, J. (2026). Countermovement Jump Performance and Sprint Speed in Chilean Adolescent Athletes: Does the Association Differ by Sex?. Applied Sciences, 16(21), 10773. https://doi.org/10.3390/app162110773
Vancouver
Hernández-Mosqueira C, Luna-Villouta P, Castillo-Quezada H, Delgado-Floody P, Pavez-Adasme G, Peña-Troncoso S, et al. Countermovement Jump Performance and Sprint Speed in Chilean Adolescent Athletes: Does the Association Differ by Sex?. Applied Sciences. 2026;16(21):10773. doi:10.3390/app162110773
BibTeX
@article{HernndezMosqueira2026,
author = {Hernández-Mosqueira, Claudio and Luna-Villouta, Pablo and Castillo-Quezada, Humberto and Delgado-Floody, Pedro and Pavez-Adasme, Gustavo and Peña-Troncoso, Sebastián and Hermosilla-Palma, Felipe and Espinoza-Gutiérrez, Roberto and Calleja-Nuñez, Juan J. and Aburto-Corona, Jorge A. and Leschot-Gatica, Jorge},
title = {Countermovement Jump Performance and Sprint Speed in Chilean Adolescent Athletes: Does the Association Differ by Sex?},
journal = {Applied Sciences},
year = {2026},
volume = {16},
number = {21},
pages = {10773},
doi = {10.3390/app162110773}
}
EUVIMED